Roche (SIX: RO, ROG; OTCQX: RHHBY) and Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced that they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio’s highly-optimized, multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B. The licensed compounds are currently in preclinical development and have generated robust T-cell responses in animal… Read More »
Roche and Inovio Pharmaceuticals partner on Inovio’s prostate cancer and hepatitis B immunotherapy products
2013 BIO International Convention Exhibition
VGXI will be exhibiting at the 2013 BIO International Convention being held on April 22-25 in Chicago, Illinois. We will be located in the Contract Services Zone at Booth 1873. Make sure you stop by and check out what we have to offer. We can’t wait to see you there!
[BLOG] Dengue Fever 101
Since it became a global issue during World War II, researchers and scientists have been struggling to develop a vaccine for Dengue fever. To date, there has been no success in eradicating this disease. Before we get to the specifics of the challenges this disease presents, let’s cover the symptoms related to this tropical disease…. Read More »
DNA Vaccine for Malaria Demonstrates Ability to Kill Infected Cells
A new potential vaccine for malaria is gaining media attention after successful pre-clinical trials in small animals and non-human primates. Until now, the most effective malaria vaccine in human clinical trials has been GSK’s RTS,S vaccine. Their vaccine demonstrated a 50% efficacy in children between the ages of 5 and 17 months and only a 30%… Read More »
Brazilian DNA Vaccine for AIDS to be Tested in Rhesus Monkeys
In development since 2001, the HIVBr18 DNA vaccine developed at the Medical School at the University of Sao Paulo (USP) in Brazil may prevent transmission of human immunodeficiency virus (HIV) and development of acquired immune deficiency syndrome (AIDS). The DNA Vaccine encodes 18 conserved multiple HLA-DR-binding HIV-1 CD4 epitopes capable of eliciting broad CD4(+) T… Read More »
Combination Cell & Gene Therapy for Brain Metastases of Breast Cancer
New research out of the UCLA Jonsson Comprehensive Cancer Center (JCCC) led by Carol Kruse, professor of neurosurgery, combined two therapies currently undergoing individual clinical trials to determine if the two used in tandem could demonstrate a greater efficacy and reduction of tumor size than either therapy alone. Dr. Kruse’s combination therapy includes both a… Read More »
VGXI Will Exhibit and Present Poster at ASGCT 2013
What Makes VGXI the Best Contract Manufacturing Organization?
VGXI was awarded the Vaccine Industry Excellence (ViE) Award for Best Contract Manufacturing Organization at the 6th Annual ViE Awards Ceremony held at the World Vaccine Congress on April 17th, 2013 in Washington, D.C. To read the full Press Release – click here. The following five categories illustrate what makes VGXI the Best Contract Manufacturing Organization… Read More »
VGXI Wins ViE Award for Best Contract Manufacturing Organization
VGXI announced today that it won the award for Best CMO at the 6th Annual ViE Awards Ceremony held at the 2013 World Vaccine Congress in Washington, D.C.. FOR IMMEDIATE RELEASE: The Woodlands, TX – April 19, 2013 – VGXI, Inc., a leading provider of DNA plasmid manufacturing and development services, is proud to announce… Read More »
Cell Line Optimization for DNA Vaccine Production
“Therapeutic plasmid DNA vector” is promising technology for the future of gene therapy. Though still in the clinical trial stage, DNA vaccines have great potential of being successful as effective vaccination technology with negligible side effects. One of the most important considerations in designing a successful DNA vaccine production process is the selection of an… Read More »
BIO International 2013
VGXI will exhibit at the 2013 BIO International Convention in Chicago, IL on April 22-25. We will be located at Booth 1873 in the Contract Services Zone.
2013 BIO International Convention Exhibition
VGXI will be exhibiting at the 2013 BIO International Convention being held on April 22-25 in Chicago, Illinois. We will be located in the Contract Services Zone at Booth 1873. Make sure you stop by and check out what we have to offer. We can’t wait to see you there!